Publication | Closed Access

Irinotecan-loaded double-reversible thermogel with improved antitumor efficacy without initial burst effect and toxicity for intramuscular administration

Initial Burst EffectOncologyMedicineMetronomic TherapyIrinotecan-loaded Double-reversible ThermogelPharmacotherapyAnti-cancer AgentPharmacologyRadiation OncologyIntramuscular Administration